{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(4)"],"submitter":["Wong B"],"pubmed_abstract":["<h4>Background</h4>Ventricular arrhythmias (VAs) are life-threatening arrhythmias which are associated with significant morbidity and mortality. Ventricular arrhythmias are induced by a change in the myocardial environment altering cardiomyocyte electrophysiology. The substrate for VA includes myocardial scar, electrolyte disturbances, and drugs altering cellular electrophysiology.<h4>Case summary</h4>Here, we present a case of a 52-year-old man with known ischaemic cardiomyopathy, presenting with VA storms secondary to dapsone, an anti-microbial used in this case for the prophylaxis of pneumocystis pneumonia. This is the first case linking dapsone to the development of VAs. Ventricular arrhythmias storm occurred towards the end of the course of anti-microbial therapy and the patient was r"],"journal":["European heart journal. Case reports"],"pagination":["1-6"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6939790"],"repository":["biostudies-literature"],"pubmed_title":["A first case report of dapsone inducing recurrent ventricular arrhythmia."],"pmcid":["PMC6939790"],"pubmed_authors":["Buckley J","Wong B","Saiva L","Galvin J"],"additional_accession":[]},"is_claimable":false,"name":"A first case report of dapsone inducing recurrent ventricular arrhythmia.","description":"<h4>Background</h4>Ventricular arrhythmias (VAs) are life-threatening arrhythmias which are associated with significant morbidity and mortality. Ventricular arrhythmias are induced by a change in the myocardial environment altering cardiomyocyte electrophysiology. The substrate for VA includes myocardial scar, electrolyte disturbances, and drugs altering cellular electrophysiology.<h4>Case summary</h4>Here, we present a case of a 52-year-old man with known ischaemic cardiomyopathy, presenting with VA storms secondary to dapsone, an anti-microbial used in this case for the prophylaxis of pneumocystis pneumonia. This is the first case linking dapsone to the development of VAs. Ventricular arrhythmias storm occurred towards the end of the course of anti-microbial therapy and the patient was r","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Dec","modification":"2025-04-05T15:17:57.139Z","creation":"2020-05-22T10:17:13Z"},"accession":"S-EPMC6939790","cross_references":{"pubmed":["31911974"],"doi":["10.1093/ehjcr/ytz158"]}}